Both in Pharmaceuticals
Septerna vs Xeris Biopharma Holdings
Over the past year SEPN returned +115.6% and XERS returned +23.5%; their daily moves had a correlation of 0.19.
SEPN +115.6% XERS +23.5%Growth of $1, one year, split-adjusted
| Metric | SEPN | XERS |
|---|---|---|
| Price | $39.13 | $9.98 |
| Market cap | $1.83B | $1.82B |
| Today | −1.53% | +1.53% |
| 1 month | +0.6% | +17.7% |
| 6 months | +67.9% | +78.2% |
| Year to date | +40.4% | +27.1% |
| 1 year | +124.2% | +22.0% |
| Revenue growth (YoY) | +22375.6% | +28.7% |
| Gross margin | 100.0% | 86.4% |
| Net margin | −48.7% | −33.8% |
| P/E (TTM) | — | — |
| Price / sales | 18.5× | 5.4× |
| Net cash | $372.3M | -$130.8M |
| Dividend yield | — | — |
| Volatility (60d) | 67.2% | 51.6% |
| Short % of float | 9.9% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).